[Treatment of acute lymphoblastic leukemia in adults using higher doses of cytostatic agents]. 1980

B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević
November 1995, Pediatria polska,
B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević
January 1989, Gematologiia i transfuziologiia,
B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević
January 1985, Hematological oncology,
B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević
January 2012, Critical reviews in oncology/hematology,
B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević
April 2015, Der Internist,
B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević
September 2012, Current opinion in oncology,
B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević
December 2023, Hematology. American Society of Hematology. Education Program,
B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević
January 2007, Nihon rinsho. Japanese journal of clinical medicine,
B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević
January 2008, Hematology. American Society of Hematology. Education Program,
B Banićević, and M Ristić, and I Vulević, and N Pastrakuljić, and R Urosević
June 2017, Current hematologic malignancy reports,
Copied contents to your clipboard!